Curcumin-Induced Apoptosis Pathways in Positive and Negative Human Epidermal Growth Factor Receptor Breast Cancer Cells

被引：1
|
作者：
Ali, Mohammed [1 ]
Smiley, Rebecca [1 ]
机构：
[1] William Beaumont Army Med Ctr, El Paso, TX 79920 USA
来源：
FASEB JOURNAL | 2020年 / 34卷
关键词：
D O I：
10.1096/fasebj.2020.34.s1.02326
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Updates on the treatment of human epidermal growth factor receptor type 2-positive breast cancer
    Kim, Miriam
    Agarwal, Surbhi
    Tripathy, Debu
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2014, 26 (01) : 27 - 33
  • [42] Prevention of brain metastases in human epidermal growth factor receptor 2-positive breast cancer
    Eberst, Lauriane
    Bailleux, Caroline
    Bachelot, Thomas
    CURRENT OPINION IN ONCOLOGY, 2020, 32 (06) : 555 - 560
  • [43] Individualizing Adjuvant Therapy in Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Node-Positive Breast Cancer
    Gogineni, Keerthi
    Kalinsky, Kevin
    JCO ONCOLOGY PRACTICE, 2022, 18 (04) : 247 - +
  • [44] Controversies of radiotherapy in human epidermal growth factor receptor (HER)-2 positive breast cancer patients
    Kolarova, Iveta
    Melichar, Bohuslav
    Vanasek, Jaroslav
    Ryska, Ales
    Horackova, Katerina
    Petera, Jiri
    Vosmik, Milan
    Sirak, Igor
    Dolezel, Martin
    BIOMEDICAL PAPERS-OLOMOUC, 2021, 165 (01): : 19 - 25
  • [45] The epidemiology, treatments and outcomes of patients with hormone receptor positive, human epidermal growth factor receptor 2 negative, node-positive early breast cancer in Taiwan
    Tang, Chao-Hsiun
    Newson, Rachel Sarah
    Lin, Ching-Hung
    Chan, Bill Hoi-Fong
    Wang, Bruce C. M.
    Shen, Shih-Pei
    Shao, Serena Yu-Ju
    FUTURE ONCOLOGY, 2024, 20 (37) : 2983 - 2992
  • [46] Tyrosine kinase inhibitors and human epidermal growth factor receptor-2 positive breast cancer
    Abunada, Aya
    Sirhan, Zaid
    Thyagarajan, Anita
    Sahu, Ravi P.
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2023, 14 (05): : 198 - 202
  • [47] Trastuzumab emtansine in human epidermal growth factor receptor 2-positive breast cancer: a review
    Mathew, Jacob
    Perez, Edith A.
    CURRENT OPINION IN ONCOLOGY, 2011, 23 (06) : 594 - 600
  • [48] Human epidermal growth factor receptor 2 testing in breast cancer
    Nielsen, Kirsten Vang
    Jorgensen, Jan T.
    Schonau, Andreas
    Oster, Anne
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (25) : 4020 - 4020
  • [49] Sphingosine kinase-1 inhibition sensitizes curcumin-induced growth inhibition and apoptosis in ovarian cancer cells
    Yang, Yan-li
    Ji, Chao
    Cheng, Lei
    He, Li
    Lu, Chun-cheng
    Wang, Rong
    Bi, Zhi-gang
    CANCER SCIENCE, 2012, 103 (08) : 1538 - 1545
  • [50] Human epidermal growth factor receptor 2 testing in breast cancer
    Nielsen, Kirsten Vang
    Jorgensen, Jan T.
    Schonau, Andreas
    Oster, Anne
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2007, 131 (09) : 1330 - 1330
12345